PEER REVIEW ARTICLES

2013

1. Gish RG, Chang, Lai CL, Ade Man R. Quantitative Hepatitis B surface antigen analysis i
Hepatitis B E-antigen in positive, nucleoside-nave patients treated with encantavir,
antiviral therapy, AVT-12-OA-2806.R1, 2013 Mar(6).

2. Gish RG, Hana YD, Kane S, Clark M, Mangahas M, Baqai S, Winters M, Proudfoot, J,
Glenn JS,. Coinfection with Hepatitis B and D: epidemiology, prevalence and disease in
patients in northern California.

3. Gish RG, et al, One-Step Real-Time PCR Assay for Detection and Quantitation of
Hepatitis D Virus RNA"; Journal of Virological Methods, # VIRMET-D-13-00111R1.

2014

4. Kim S, Syed G, Khan M , Chiu W, Sohail M, Gish R, Siddiqui A, "Hepatitis C Virus
Triggers Mitochondrial Fission and Attenuates Apoptosis to Promote Viral Persistence
Proc Natl Acad Sc,#:2013-21114RR 19Mar-2014.

5. Wong RJ, Gish RG; Implementing Best Practices When Initiating Hepatitis B Virus
Therapy, Clin in Liv Dis, Apr-2014.

6. Gish RG, Gutierrez JA, Navarro-Cazarez N, Giang K, Adler D, Tran B, Locarnini S,
Hammond R, Bowden S; A simple and inexpensive point-of-care test for hepatitis B
surface antigen detection: serological and molecular evaluation, Journal of Viral Hep,
doi:10.1111/jvh.12257, accepted for publication, 15 March 2014.

7. Wong RJ, Gish, RG, Aijaz, A; Hepatic Encephalopathy is Associated with Significantly
Increased Mortality among Patients Awaiting Liver Transplantation, Journal of Liver
Transplant, accepted for publication, 8 June 2014.

8. Ahn J, Gish, RG., Hepatitis D in 2014- a Call to Screening, accepted for publication,
Gastroenterology Hepatology, accepted for publication, 8 June, 2014.

9. Gish RG, Kono Y, Kartik J, Loomba R, Patton H , Alexander K, Mendler M;
Hepatocellular Carcinoma Surveillance: A National Survey of Current Practices in the
United States, Digestive Disease Science Journal, manuscript ID# DDSJ-D-14-00596R,
accepted for publication, 14June 2014.

10. Gish RG, Lands L, et al; Immunosuppression in Patients with Chronic Hepatitis B,
Current Hepatology Reports, Article 238, DOI: 10.1007/s11901-014-0238-2, Editorial
manuscript number: HEPS-D-14-00018.0, accepted for publication, 11 June 2014.

11. Seetharam A, Perillo RP, Gish RG; Immunosuppression in Patients with Chronic
Hepatitis B, DOI 10.1007/s11901-014-0238-2; Curr Hepatology Rep; 21 June 2014.

12. Perillo RP, Gish RG, Seetharam A, Lands L; Medical Interventions Associated with HBV
Reactivation: Common and Less Common, Clinical Liver Disease, Manuscript ID CLD-
14-0060, 10 July 2014.

13. Perillo RP, Gish RG, FalckYtter YT; American Gastroenterological Association Institute
Technical Review on Prevention and Treatment of Hepatitis B Reactivation during
Immunosuppressive Drug Therapy; Gastroenterology Press, 2014.

14. Donald G. Mitchell DG, Bruix J, Sherman M, Sirlin CB; LI-RADS (Liver Imaging
Reporting and Data System): Summary, Discussion, and Consensus of the LI-RADS
Management Working Group and Future Directions; Manuscript ID HEP-14-
0736.R1.27304; Heptalology 18July, 2014; co-author via the study consortium and
acknowledgements.

SUBMITTED FOR PUBLICATION

1. Gish RG. Successful domino liver transplantation from a patient with methylmalonic
acidemia: first ever report. American Association for the Study of Liver Disease, Liver
Transplantation, Manuscript ID LT-12-522.R1; 2013 Mar (6).

2. Gish RG, Gutierrez J, Navarro-Cazarez N, Giang K, Adler, D, Tran B, Locarnini S,
Hammond R, Bowden D. A simple and inexpensive point-of-care test for hepatitis B
surface antigen detection: serological and molecular evaluation. Submitted for
publication. Journal of Vir Hep; 2013 Dec, JVH-00600-2013.

3. Gish, RG, Mendler M, Kono Y, Joshi K, Loomba R, Kuo A, Patton H. HCC
Surveillance: An Inquiry into Current Practices in the United States: National Survey of
HCC Surveillance Practices. Am Journ of Gastroentrol; Dec 2013. Submitted for
publication.

4. Joshi K, Mendler M, Gish RG, Loomba R, Kuo A, Patton H, Kono Y. HCC: Surveillance:
An Inquiry into Current Practices in the United States, American Journ of Gastroentrol,
Submitted for publication; 18 Dec-2013. Manuscript ID: AJG-13-2307.

5. Wong RF, Gish RG, Aijza, A: Hepatic Encephalopathy is Associated with Significantly
Increased Mortality Among Patients Awaiting Liver Transplantation, submitted for 5
Mar-2014.

6. Baqai SF, Hana D, Zeng L, Gish RG. Entecavir Effective for Both Treatment-
Experienced and Treatment-Nave Chronic Hepatitis B Patients in Real Life Settings,
Lark Scientific, submitted for publication, Mar-2014.

7. Mitchell, DG, Bruix, J, Sherman, M, Sirlin, CB. Gish, RG. RADS (Liver Imaging
Reporting and Data System): Summary, Discussion, Consensus of the LI-RADS
Management Working Group and Future Directions. Journ of Hep: submitted for
publication, 30 Mar-2014.

8. Gish RG, Wong, et al., Etiology of Underlying Liver Disease Impacts Post-Liver
Transplantation Survival among Patients with Hepatocellular Carcinoma, Hepatology,
Manuscript ID HEP-14-1069, submitted for publication, 7 May 2014.

9. Baqai S, Proudfoot J, Yi D, Mangahas M, Gish RG, High rate of core promoter and
precore mutations in patients with chronic hepatitis B and their impact on the liver
disease, submitted for publication, Hepatology International, submitted for publication,
25 May 2014.

10. Gish RG, Brosgart CL, Clary R, Block JM, Block TM, Lelt, Knowdley KV; The CDC
Underestimates the Prevalence of Chronic Hepatitis B in the U.S., advocacy letter
submitted for publication, Hepatology, 11 June 2014.

11. Gish RG, Brosgart CL, Clary R, Block JM, Block TM, Lelt, Knowdley KV; The CDC
Underestimates the Prevalence of Chronic Hepatitis c in the U.S., advocacy letter
submitted for publication, American Association for the Study of Liver Disease (AASLD),
11 June 2014.

12. Gish RG, Wong, et al., Etiology of Underlying Liver Disease Impacts Post-Liver
Transplantation Survival among Patients with Hepatocellular Carcinoma, American
Association for the Study of Liver Disease, manuscript ID# LT-14-348, submitted for
publication, 24 June 2014.

13. Wong RJ, Gish, RG, Aijaz, A., Hepatic Encephalopathy is Associated with Significantly
Increased Mortality Among Patients Awaiting Liver Transplantation" American
Association for the Study of Liver Disease, manuscript ID# LT-14-198.R3, submitted for
publication, 26 June 2014.

14. Reddy KR, Beavers KL, Hammond SP, Lim JK, Lim, Falck-Ytter YT, et al., American
Gastroenterological Association Institute Guideline on the Prevention and Treatment of
Hepatitis B Reactivation During Immunosuppressive Drug Therapy, Gastroenterology,
submitted for publication, 26 June 2014.

15. Wong RJ, Gish RG, Implementing Best Practices When Initiating Hepatitis B Virus
Therapy, Vindico Medical Education; http://www.vindicomeded.com, monograph
submitted for publication; 11 July 2014.

REVIEW ARTICLES

1. Gish, RG, Marrero, J., Finn R. Extending survival with the use of targeted therapy for the
treatment of hepatocellular carcinoma. CAHO/G&H roundtable monograph, Clinical
Advances in Hematol/Oncol, Millennium Medical Publishing, Inc. 2013 Feb;4: page
numbers. Review.
2. Gish RG. Strategies for hepatocellular carcinoma surveillance and diagnosis.
Gastroenterol Hepatol. 2013 Apr;V9(4): page numbers. Review.
3. Noureddin M, Gish RG. Hepatitis Delta: Epidemiology, Diagnosis and Management: 36
Years After Discovery. Curr Gastroenterol Rep (2014) 16:365; Springerlink.com, 30 Nov
2013. Review.
BOOK CHAPTERS & EDITORIALS
1. Guitierrez JA, Gish RG; Efficacy of combination treatment modalities for intermediate
and advanced hepatocellular carcinoma: intra-arterial therapies, sorafenib and novel
small molecules; Transl Cancer Res, Manuscript ID TCR-13-113, DOI:
10.3978/j.issn.2218-676X.2013.10.01; Pioneer Bioscience Publishing Company,
www.thetcr.org; 25 Nov 2013.


EDITOR / REVIEWER

1. Hepatitis B: Treatment and Clinical Trials abstract review committee, American
Association for the Study of Liver Diseases (AASLD) Digestive Disease Week (DDW).
January 4, 2013.

2. MD Thesis (Professor Chan See Ching). External Reviewer / Examiner, The University
of Hong Kong. May 31, 2013.

3. American Gastroenterological Association (AGA) Technical Review Author for AGA
Guidelines for Antiviral Therapy for HBV Reactivation in Setting of Immunosuppressive
Therapy, June 2013.

4. Public Library of Science, Manuscript #: PONE-D-13-28265; High Prevalence and
Significance of Hepatitis D Virus Infection among Treatment-nave HBsAg-Positive
Patients in Northern Vietnam; 2013.

5. Digestive Diseases and Sciences, (DDSJ-D-13-01088); Primary Surgical Resection
versus Liver Transplantation for Transplant-Eligible Hepatocellular Carcinoma Patients,
2013.

6. Department of Health & Human Services, Agency for Healthcare Research and Quality
(AHRQ) Evidence-based Practice Center (EPC) Program, Peer Reviewer, 2012 2013.

7. High Prevalence and Significance of Hepatitis D Virus Infection among Treatment-nave
HBsAg-Positive Patients in Northern Vietnam, Public Library of Science (PLOS ONE),
PONE-D-13-28265R1, August 2013.

8. "Zinc Monotherapy is Effective in Wilsons Disease Patients with Mild Liver Disease
Diagnosed in Childhood: A Retrospective Study," Alimentary Pharmacology &
Therapeutics - APT-0841-2013, August 2013. 2013: Abstract Reviewer, Primary
Surgical Resection versus Liver Transplantation for Transplant-Eligible Hepatocellular
Carcinoma Patients" (DDSJ-D-13-01088R); Digestive Diseases and Sciences, 2013.

9. Peer Abstract Reviewer, Digestive Disease Week 2014, American Association for the
Study of Liver Disease, McCormack Place, Chicago, IL

10. Digestive Disease Week 2014: American Association for the Study of Liver Disease
(AASLD) Abstract Reviewer, Jan-2014.

11. Reviewer, Chronic hepatitis B prevalence among children and mothers: results from a
nationwide, population-based survey in Lao People's Democratic Republic, Open
Access Public Library of Science, PONE-D-13-44773R1, EMID:ccb2186b7e4e406c,
15Jan-2014.

12. Reviewer, Hepatitis B virus and Hepatitis C Virus Infections in United States-bound
Refugees from Asia and Africa, American Journal of Tropical Medicine and Hygiene,
AJTMH-14-0068, 5Feb-2014.

13. Reviewer, Seetharam A, Perrillo R, Gish RG. Immunosuppression in patients with
chronic Hepatitis B, The Liver Meeting 2014 presented by the American Association for
the Study of Liver Disease (AASLD), 3Mar-2014.


ABSTRACTS

1. Maja Kodani, Alyssa Martin, Tonya Mixson-Hayden, Jan Drobeniuc, Robert Gish, and
Saleem Kamili, One-Step Real-Time PCR Assay for Detection and Quantification of
Hepatitis D Virus RNA by Short-Form Paper, Journal of Clinical Microbiology, Virology
Section, Control number JCM00554-13; February 26, 2013

2. Robert G. Gish, Ting-Tsung Chang, Ching-Lung Lai, Robert A de Man, Adrian Gadano,
Cyril Llamoso, Hong Tang: Quantitative Hepatitis B Surface Antigen Analysis in
Hepatitis B e Antigen-Positive, Nucleoside-Naive Patients Treated With Entecavir,
Antiviral Therapy, Manuscript ID AVT-12-OA-2806.R1, doi: 10.3851/IMP2559,
International Medical Press Ltd.,
http://www.intmedpress.com/journals/avt/abstract.cfm?id=2559&pid=48; February 28,
2013.

3. Maja Kodani, Alyssa Martin, Tonya Mixson-Hayden, Jan Drobeniuc, Robert Gish,
Saleem Kamili, One-Step Real-Time PCR Assay for Detection and Quantification of
Hepatitis D Virus RNA One-Step qRT-PCR for HDV Detection, Journal of Clinical
Microbiology, Virology Section, JCM0054-13, March 2013.
4. Robert B. Gish, Strategies for Hepatocellular Carcinoma Surveillance and Diagnosis,
Gastroenterology & Hepatology, April 2013 Volume 9, Issue 4.

5. Impact of Entecavir Versus Lamivudine on Hepatic HBV Covalently Closed-Circular
DNA and Total Hepatic HBV DNA in Nucleoside-Nave HBeAg Positive Chronic
Hepatitis B Patients, Robert G. Gish, Scott Bowden, Stephen Locarnini, Ting-Tsung
Chang, You-Chen Chao, Kwang-hyub Han, Robert de Man, Cyril Llamoso, Hong
Tang, DDW, Orlando Florida oral presentation , Funded by Bristol-Myers Squibb; May
2013.

6. Shirley M. Tsunoda, Stephanie Wang, Linda Awdishu, Nina Phak, Alicia Somers, Robert
G. Gish, Utilizing Intracellular ATP Activity as a Biomarker for Predicting Rejection in
Hepatitis C Liver Transplant, submitted to 2013 ATC Conference; May 2013.

7. Robert G. Gish, Shirley M. Tsunoda, Jonathan Hu et al, Effect of Hepatitis C Therapy on
Immune Cell Function Assay in Liver Transplant Recipients, submitted to 2013 ATC
Conference; May 2013.

8. Scott Bowden, Stephen Locarnini, Ting-Tsung Chang, You-Chen Chao, Kwang-hyub
Han, Robert G. Gish, Robert de Man, Cyril Llamoso7, Hong Tang, Impact of Entecavir
Versus Lamivudine on Hepatic HBV Covalently Closed-Circular DNA and Total Hepatic
HBV DNA in Nucleoside-Nave HBeAg Positive Chronic Hepatitis B Patients, e-Poster,
Lecture collateral, Digestive Disease Week, Orlando, FL.; May 1921, 2013.

9. Speaker, Current Insights in to the Management of Hepatic Encephalopathy, Hepatology
Centers of Educational Expertise, San Diego, CA; May 28, 2013.

10. Session Chairman, Transforming Science to Clinical Practice, APASL Liver Week 2013
Singapore: Session Chairman, Singapore; June 6-10, 2013.

11. Dr. Robert Gish, Dr. Lynn Huang, Hec1 as a Novel Approach to Liver Cancer, submitted
for publication, June 24, 2013.

12. Maja Kodania, Alyssa Martina, Tonya Mixson-Haydena, Jan Drobeniuca, Robert R.
Gish, Saleem Kamilia; One-Step Real-Time PCR Assay for Detection and Quantitation
of Hepatitis D Virus RNA, Journal of Virological Methods 193 (2013), pp. 531-535,
August 2013.

13. Wyles D, Nelson D, Swain M, Gish RG, Ma J, McNally J, Brainard D, Symonds W,
McHutchison J, Bernstein D, Thompson A, Mangia A, Jacobson I. On Treatment HCV
RNA as a Predictor of Virologic Response in Sofosbuvir-Containing Regimens for
Genotype 2/3 HCV Infection: Analysis of the FISSION, POSITRON, and FUSION
Studies. American Association for the Study of Liver Disease, The Liver Meeting.
Washington DC. November 1-5, 2013.

14. Scott Bowden, Stephen Locarnini, Ting-Tsung Chang, You-Chen Chao, Kwang-hyub
Han, Gish RG, Robert de Man, Cyril Llamoso, Hong Tang. Impact of Entecavir Versus
Lamivudine on Hepatic HBV Covalently Closed-Circular DNA and Total Hepatic HBV
DNA in Nucleoside-Nave HBeAg Positive Chronic Hepatitis B Patients. Australian
Gastroenterology Week 2013. Melbourne, Australia. October 7-9, 2013.

15. Gish RG et al; Hepatocellular Carcinoma Surveillance: An Inquiry Into Current
Practices, Abstract #ILCA2013-1080, International Liver Cancer Association Seventh
Annual Conference, Washington D.C., September 13-15, 2013.

16. Luke Huang; Simon Shih-Hsien Chuang, KJ Kao, Diana Wu; Jinn Wu, Gish, Robert;
Johnson Lau; Inhibition of Hec1 as a Novel Approach to the Treatment of Primary Liver
Cancer, Taivex Therapeutics, 2013.

17. Gish RG, VIRGIL ((Vigilance Against Viral Resistance) Study Establishes Clinical
Benefit of Virologic Suppression With Entecavir, Commentary, Clinical Care Options,
Virology, September, 2013.

18. Gish RG, Delta Virus Infection: Epidemiology and Initiatives to Intercept It,
Commentary, Gastroenterology & Hepatology, September 2013

19. Gish RG, Global Hepatitis Overview and How to Respond to the Epidemic, Armenia
Liver Conference 2013, September 6-8, 2013.

20. Gish RG, Current Therapy of Hepatitis B: Planning for 2013 and Beyond, Armenia
Liver Conference 2013, September 6-8, 2013.

21. Gish RG, Hepatitis E, Armenia Liver Conference 2013, September 6-8, 2013.

22. Gish RG, Hepatitis C Virus: The Basics, Current Status and the Future, Armenia Liver
Conference 2013, September 6-8, 2013.

23. Gish RG et al; Utility of On-Treatment HCV RNA as a Predictor of Response, American
Association for the Treatment of Liver Disease, The Liver Meeting, Washington D.C.,
November 1-5, 2013.

24. Gish RG, et al, On Treatment HCV RNA as a Predictor of Virologic Response in
Sofosbuvir-Containing Regimens for Genotype 2/3 HCV Infection, The Liver Meeting,
AASLD 2013, Washington DC, November 1-5, 2013.

25. Gish RG et al, Impact of Entecavir Versus Lamivudine on Hepatic HBV Covalently
Closed-Circular DNA and Total Hepatic HBV DNA in Nucleoside-Nave HBeAg Positive
Chronic Hepatitis B Patients. ISGCON 2013 - Indian Society of Gastroenterology
Conference, Gujarat, Ahmedabad , India; November 28 December 2013.

26. Sandy Chong et al, Collaborative Efforts to Screen at-risk Populations for Hepatitis B
and C in San Diego County, abstract approved for HepDart 2013, Kohala, Hawaii,
December 10, 2013.

27. Nguyen CT, Gish RG, et al; POC Testing for Hepatitis C Screening at Community-
Based-Organizations Facilitates Disease Control, abstract approved for HepDart 2013,
Kohala, Hawaii, December 10, 2013.

28. Julio Gutierrez, et al, Efficacy of Screening for Hepatitis B Infection and Immunity in Low
Resource Settings with an Inexpensive Point of Care Immunoassay, abstract approved
for HepDart 2013, Kohala, Hawaii, December 10, 2013.

29. Lillian Nguyen, et al, Cost-Effectiveness Analysis of Point of Care versus Standard of
Care Tests for Hepatitis B in Asian and Pacific Islanders in San Diego County, abstract
approved for HepDart 2013, Kohala, Hawaii, December 10, 2013.

30. Xuan Phan, et al, Targeting Populations At-Risk for Hepatitis B Using the Research
Electronic Data Capture (RED Cap) Program, abstract approved for HepDart 2013,
Kohala, Hawaii, December 10, 2013.

31. Lillian Nguyen, et al, Cost-Effectiveness Analysis of Point of Care versus Standard of
Care Tests for Hepatitis B in Asian and Pacific Islanders in San Diego County, poster
submitted to European Association for the Study of Liver Diseases (EASLD); Spring
2014

32. Sandy Chong et al, Collaborative Efforts to Screen at-risk Populations for Hepatitis B
and C in San Diego County, poster submitted to European Association for the Study of
Liver Diseases (EASLD), Spring 2014.

33. Julio Gutierrez, et al, Efficacy of Screening for Hepatitis B Infection and Immunity in Low
Resource Settings with an Inexpensive Point of Care Immunoassay, poster submitted
to European Association for the Study of Liver Diseases (EASLD), Spring 2014.

34. Xuan Phan, et al, Targeting Populations At-Risk for Hepatitis B Using the Research
Electronic Data Capture (RED Cap) Program, poster submitted to European
Association for the Study of Liver Diseases (EASLD), Spring 2014.

35. Christina Thuy Nguyen, et al; POC Testing for Hepatitis C Screening at Community
Based Organizations Facilitates Disease Control, poster submitted to European
Association for the Study of Liver Diseases (EASLD), Spring 2014.

36. Kono Y, Gish RG. HCC Surveillance: An Inquiry into Current Practices in the United
States . Poster submitted for Digestive Disease Week 2014. CID: 1901686. McCormick
Place Convention Center, Chicago, IL. 5 May-2014.


37. Chong SI, Gish RG, Nguyen C, Tran BN, Tsunoda S, Navarro-Cazarez N, Gutierrez J, P
Taylor P: Collaborative Efforts to Screen At-Risk Populations for Hepatitis B and C in
San Diego County: Singapore Hepatitis Conference, 6-7 June-2014.

38. Nguyen L.T., Tran BN, Fontanesi J, Gish RG; Cost-Effectiveness Analysis of Point-of
Care versus Standard of Care Tests for Hepatitis B in Asian and Pacific Islanders;
Singapore Hepatitis Conference, 6-7 June-2014.

39. Given BD, Locarnini A, Schluep T, Lau J, Lewis D, Gish RG, Lickliter J., A Phase I, first
in human clinical trial of ARC-520, a siRNA-based therapeutic for the treatment of
chronic hepatitis B virus infection, in normal healthy volunteers, submitted for
publication, American Association for the Study of Liver Disease 2015., June 2014.

40. Gish, RG, Tran B, Nyguyen C, Pharm D., Cost effectiveness Analysis of Point-of-care
versus Standard of Care Tests for Hepatitis B in Asian and Pacific Islanders, Poster
Abstract presentation, Singapore Hepatitis Conference 2014, Singapore, June 5-7,
2014.

41. Gish, RG, Tran B, Nyguyen C, Pharm D., Point-of-care testing for hepatitis C screening
at Community-Based-Organizations facilitates disease control, Poster Abstract
presentation, Singapore Hepatitis Conference 2014, Singapore, June 5-7, 2014.

42. Gish, RG, Tran B, Nyguyen C, Pharm D., Targeting populations at risk for hepatitis B
using the Research Electronic Data Capture Program (REDCap), Poster Abstract
presentation, Singapore Hepatitis Conference 2014, Singapore, June 5-7, 2014.

43. Gish, RG, Tran B, Nyguyen C, Pharm D., Pearls gained from hepatitis B screening in the
Community setting), Poster Abstract presentation, Singapore Hepatitis Conference
2014, Singapore, June 5-7, 2014.

44. Gish, RG, Tran B, Nyguyen C, Pharm D., Collaborative Efforts to screen at risk
populations for hepatitis B and C in San Diego County, Poster Abstract presentation,
Singapore Hepatitis Conference 2014, Singapore, June 5-7, 2014.